* LPCN 1148 comprises testosterone dodecanoate, a unique androgen receptor agonist
https://www.lipocine.com/news-article/fda-grants-fast-track-designation-to-lipocine-for-lpcn-1148-as-a-treatment-for-sarcopenia-in-patients-with-decompensated-cirrhosis/
SALT LAKE CITY, Dec. 17, 2024...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.